Immune Pharmaceuticals Ltd.

10/12/2014

Listen to Immune Pharmaceuticals, Inc. CEO Dr. Daniel Teper, radio interview at iHeartRadio http://youtu.be/VncoZEJt9W8

IMMUNE Pharmaceuticals, Inc. (NASDAQ: IMNP) applies a personalized approach to treatment, developing novel, highly targeted antibody therapeutics to improve ...

12/11/2014

Immune's CEO To Present on Personalized Medicine at the 2014 NY/ NJ CEO Biotech Conference. Immune developing personalized medicine drugs for auto-immune diseases and cancer http://money.cnn.com/news/newsfeeds/articles/prnewswire/NY62938.htm

NEW YORK and HERZLIYA PITUACH, Israel, Nov. 11, 2014 /PRNewswire/ -- Immune Pharmaceuticals Inc. (NASDAQ: IMNP) announced that Dr. Daniel Teper, Chairman & CEO, will discuss personalized medicine at a panel taking place on Thursday, November 13, 2014, at 9:45 a.m.

12/11/2014

Can personalized medicine change how Crohn’s Disease and Ulcerative Colitis patients are treated? https://medium.com//can-personalized-medicine-change-how-crohns-disease-and-ulcerative-colitis-patients-are-treated-45737d0ae501

hile traditional drugs typically work in no more than half of patients and sometimes induce severe side-effects, physici…

23/10/2014

New Clinical Data Supports Development Of Bertilimumab In Both Ulcerative Colitis And Crohn's Disease.
http://www.marketwatch.com/story/new-clinical-data-supports-development-of-bertilimumab-in-both-ulcerative-colitis-and-crohns-disease-2014-10-22

20/10/2014

The Race To Stop Ebola: who will get results first. https://medium.com//the-race-to-stop-ebola-who-will-get-results-first-890520f477d2

Research for prevention and treatment of infectious disease is traditionally underfunded by the industry and by governme…

18/10/2014

Fred Hassan on reinventing your company through culture https://medium.com//fred-hassan-on-reinventing-your-company-through-culture-10449a7bab7a

Fred Hassan is recognized as the ultimate corporate re-inventor and serial achiever. I had the privilege to be part of h…

17/10/2014

Are Inversion M&As going out of fashion? https://medium.com//are-inversion-m-as-going-out-of-fashion-e69fd3b9d5fb

With the US Corporate Tax Rate being one of the highest in the world, many Pharma exec have been looking at reducing the…

17/10/2014

New CEO Blog is up and running! Follow me on Medium : https://medium.com/

Immune Pharmaceuticals Inc. applies a personalized approach to treatment, developing novel, highly targeted antibody therapeutics to improve patients lives.

21/09/2014

Equities.com interviews Dr. Daniel Gedeon Teper, Co-Founder, Chairman and CEO Immune Pharmaceuticals http://www.equities.com/media-gallery/320-dr-daniel-gedeon-teper-co-founder-chairman-and-ceo-immune-pharmaceuticals-inc?category_id=73

Equities.com interviews Dr. Daniel...

21/09/2014

Equities.com interviews Dr. Karin Henenberger, Chief Strategy Officer with Immune Pharmaceuticals http://www.equities.com/media-gallery/324-dr-karin-henenberger-chief-strategy-officer-immune-pharmaceuticals-inc?category_id=73

Equities.com interviews Dr. Karin...

18/09/2014

Immune Pharmaceuticals Initiates Phase II Clinical Trial In Ulcerative Colitis. Published: Sept 18, 2014 http://www.marketwatch.com/story/immune-pharmaceuticals-initiates-phase-ii-clinical-trial-in-ulcerative-colitis-2014-09-18

HEADLINE2Company Recently Initiated Phase II in Bullous Pemphigoid CAMBRIDGE, Mass. and HERZLIYA PITUACH, Israel, Sept. 18, 2014 /PRNewswire/ -- Immune Pharmaceuticals Inc. IMNP, -2.22% announces today that it has initiated the screening of patients for a Phase II proof of concept clinical trial exp…